Tomotaka Shimura

Biomarker immunoprofile in salivary duct carcinomas: clinicopathological and prognostic implications with evaluation of the revised classification

Soichiro Takase, Satoshi Kano, Yuichiro Tada et al. · Oncotarget · 2017 · 114 citations · Full text

Medicine, Oncology, Pathology +17

Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas

Tomotaka Shimura, Yuichiro Tada, Hideaki Hirai et al. · Oncotarget · 2017 · 53 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Survival benefit of HER2-targeted or androgen deprivation therapy in salivary duct carcinoma

Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi et al. · Therapeutic Advances in Medical Oncology · 2022 · 43 citations · Full text

Medicine, Endocrinology, Oncology +17

Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan

Daisuke Kawakita, Yuichiro Tada, Yorihisa Imanishi et al. · Oncotarget · 2016 · 31 citations · Full text

Medicine, Oncology, Cancer Immunology +16

Prognostic Implication of Histopathologic Indicators in Salivary Duct Carcinoma

Masato Nakaguro, Yukiko Sato, Yuichiro Tada et al. · The American Journal of Surgical Pathology · 2019 · 25 citations · Full text

Veterinary Medicine, Oncology, Pathology +10